ANIP

ANI Pharmaceuticals Stock Price

33.68
0.55 (1.66%)
Upgrade to Real-Time
Regular Market
33.68

Low
23.55

52 Week Range

High
39.9999

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
ANI Pharmaceuticals Inc ANIP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.55 1.66% 33.68 13:33:30
Open Price Low Price High Price Close Price Prev Close
33.38 33.26 33.96 33.13
Bid Price Ask Price Spread News
33.78 33.96 0.18 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
406 11,499 $ 33.64 $ 386,831 - 23.55 - 39.9999
Last Trade Time Type Quantity Stock Price Currency
13:39:43 21 $ 33.87 USD

Period:

Draw Mode:

ANI Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 429.08M 12.74M 8.28M $ 208.48M $ -1.88M -1.88 -25.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -5.87k 14.80%

more financials information »

ANI Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ANIP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week32.0733.984832.0033.1244,0621.615.02%
1 Month33.1636.3632.0033.6753,7250.521.57%
3 Months33.5339.999931.0434.0560,7070.150.45%
6 Months32.4239.999927.9232.9857,9641.263.89%
1 Year26.6439.999923.5530.9964,9007.0426.43%
3 Years71.2286.9623.5552.5497,744-37.54-52.71%
5 Years58.6986.9623.5555.37112,208-25.01-42.61%

ANI Pharmaceuticals Description

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Propafenone, and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.


Your Recent History
NASDAQ
ANIP
ANI Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.